Providence First Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Buy
+4,479
New +$517K 0.19% 118
2025
Q1
Sell
-135
Closed -$13.4K 158
2024
Q4
$13.4K Buy
+135
New +$13.9K 0.01% 176
2024
Q1
Sell
-6,725
Closed -$733K 106
2023
Q4
$733K Hold
6,725
0.36% 65
2023
Q3
$692K Sell
6,725
-2,120
-24% -$228K 0.39% 63
2023
Q2
$1.02M Buy
+8,845
New +$1M 0.56% 51

Other funds holding MRK

Providence First Trust's MRK Position: Q1 2026 in Review

Providence First Trust opened a new position in Merck (MRK) in Q1 2026: 4,479 shares worth $539K. The stake represents 0.19% of the portfolio and ranks #118 among its holdings. This is a return to the name: Providence First Trust previously reported a position in MRK as recently as Q4 2024.

Providence First Trust first reported a position in MRK in Q2 2023 and has held it in 5 quarters since. The position peaked at $1.02M in Q2 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Providence First Trust held 4,479 shares of Merck worth $539K as of Q1 2026.
  • Merck was a new Providence First Trust position in Q1 2026.
  • Merck made up 0.19% of Providence First Trust's portfolio in Q1 2026, its #118 holding.
  • Providence First Trust first reported a position in Merck in Q2 2023 and has held it in 5 quarters since.
  • Providence First Trust's Merck position peaked at $1.02M in Q2 2023.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Providence First Trust's 13F filing for Q1 2026, filed 5 May 2026.